- Home
- LMAT vs CPRI Comparison
LMAT vs CPRI Comparison
Compare LMAT & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMAT
- CPRI
- Stock Information
- Founded
- LMAT 1983
- CPRI 1981
- Country
- LMAT United States
- CPRI United Kingdom
- Employees
- LMAT N/A
- CPRI N/A
- Industry
- LMAT Medical/Dental Instruments
- CPRI Apparel
- Sector
- LMAT Health Care
- CPRI Consumer Discretionary
- Exchange
- LMAT Nasdaq
- CPRI Nasdaq
- Market Cap
- LMAT 1.9B
- CPRI 2.0B
- IPO Year
- LMAT 2006
- CPRI 2011
- Fundamental
- Price
- LMAT $81.78
- CPRI $16.82
- Analyst Decision
- LMAT Buy
- CPRI Buy
- Analyst Count
- LMAT 6
- CPRI 11
- Target Price
- LMAT $100.80
- CPRI $21.91
- AVG Volume (30 Days)
- LMAT 174.9K
- CPRI 3.2M
- Earning Date
- LMAT 07-31-2025
- CPRI 08-07-2025
- Dividend Yield
- LMAT 0.98%
- CPRI N/A
- EPS Growth
- LMAT 30.45
- CPRI N/A
- EPS
- LMAT 1.97
- CPRI N/A
- Revenue
- LMAT $226,256,000.00
- CPRI $4,442,000,000.00
- Revenue This Year
- LMAT $13.88
- CPRI N/A
- Revenue Next Year
- LMAT $8.81
- CPRI $4.55
- P/E Ratio
- LMAT $41.52
- CPRI N/A
- Revenue Growth
- LMAT 13.19
- CPRI N/A
- 52 Week Low
- LMAT $71.42
- CPRI $11.86
- 52 Week High
- LMAT $109.58
- CPRI $43.34
- Technical
- Relative Strength Index (RSI)
- LMAT 47.11
- CPRI 46.41
- Support Level
- LMAT $80.04
- CPRI $16.75
- Resistance Level
- LMAT $83.15
- CPRI $17.50
- Average True Range (ATR)
- LMAT 1.93
- CPRI 0.67
- MACD
- LMAT -0.01
- CPRI -0.12
- Stochastic Oscillator
- LMAT 42.70
- CPRI 14.44
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
About CPRI Capri Holdings Limited
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. In April 2025, Capri agreed to sell Versace to Prada. John Idol has served as Capri's CEO since 2003.